Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80306 refers to a laboratory procedure designed for the presumptive testing of drugs in a patient's system. This test is utilized to detect the presence or absence of various drug classes during a specific medical encounter. Presumptive drug testing serves as an initial screening method, which is typically followed by more definitive testing to identify specific drugs and their quantitative levels. It is important to note that presumptive testing does not provide qualitative identification of individual drugs or the exact amounts present in the sample. The procedure involves obtaining a sample, which is usually blood or urine, through a separately reported procedure. The methodologies employed in this testing include immunoassays, chromatography, and mass spectrometry, which are essential for accurate detection and analysis. The code 80306 specifically indicates that the presumptive drug testing is performed using FDA-specified equipment that supports moderate complexity testing methodologies, with the results being read through instrument-assisted direct optical observation. This includes the use of various devices such as dipsticks, cups, cards, or cartridges, and may also involve sample validation processes when applicable.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 80306 is indicated for use in situations where there is a need to screen for the presence of drugs in a patient's system. This may include, but is not limited to, the following conditions:
The procedure for CPT® Code 80306 involves several key steps that ensure accurate drug testing. The following outlines the procedural steps:
After the completion of the drug testing procedure under CPT® Code 80306, the results are typically reviewed and interpreted by qualified healthcare professionals. Depending on the findings, further actions may be required, such as additional confirmatory testing for definitive drug identification. Patients may also receive counseling or referrals based on the results of the test. It is essential to document the results and any subsequent actions taken in the patient's medical record to ensure continuity of care and compliance with regulatory requirements.
| Short Descr | DRUG TEST PRSMV INSTRMNT | Medium Descr | DRUG TST PRSMV READ INSTRMNT ASSTD DIR OPT OBS | Long Descr | Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1C - Lab tests - urinalysis | MUE | 1 |
| Q5 | Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | GA | Waiver of liability statement issued as required by payer policy, individual case | 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GT | Via interactive audio and video telecommunication systems | GW | Service not related to the hospice patient's terminal condition | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | GZ | Item or service expected to be denied as not reasonable and necessary | HK | Specialized mental health programs for high-risk populations | QE | Prescribed amount of stationary oxygen while at rest is less than 1 liter per minute (lpm) | QW | Clia waived test | X2 | Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services | XE | Separate encounter, a service that is distinct because it occurred during a separate encounter |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2018-01-01 | Changed | Long and medium descriptions changed. |
| 2017-01-01 | Added | Added |
Get instant expert-level medical coding assistance.